BioMarin's Amicus Acquisition: Supply Chain Challenges
Update: 2026-01-02
Description
BioMarins acquisition of Amicus Therapeutics underscores supply chain challenges for rare disease treatments, highlighting the need for seamless integration of new manufacturing sites, shipping routes, and handling rules. With health services deals expected to rise, supply chain teams must prepare for increased volume, location shifts, and tech upgrades to ensure uninterrupted delivery of critical therapies. Checkout Solipillow.com
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
